title: Less abuse potential with XR formulation of quetiapine?
authors.forename: Lawrence
authors.initials: L
authors.lastname: Reccoppa
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003692:Delayed-Action Preparations / Q000009:adverse effects*; D003987:Dibenzothiazepines / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D000069348:Quetiapine Fumarate; D019966:Substance-Related Disorders / Q000517:prevention & control*
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate